Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3130 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

AstraZeneca files sNDA for Seroquel XR

The supplemental new drug application (sNDA) is based on seven Phase III, placebo-controlled studies that assessed the efficacy and safety of once-daily treatment with Seroquel XR in patients

Applied DNA Sciences and Smiths Detection sign MoU

Under the terms of the agreement, Smiths will provide Applied DNA Sciences (APDN) with exclusive use of the Bio-seeqPLUS platform, centered upon a portable, DNA-verifying device for authentication,

Volcano to participate in AstraZeneca’s Saturn trial

Saturn is a 104-week, parallel-group, multicentre, double-blind, Phase IIIb intravascular ultrasound (IVUS) imaging study of approximately 1,300 patients at 170 centres worldwide. This study by AstraZeneca is designed

Roxro wins award for Phase III intranasal pain drug

The double-blind, placebo-controlled study showed that ROX-888 rapidly and effectively eased pain among patients who had undergone major abdominal or orthopedic surgery. In addition, ROX-888 significantly reduced the